Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'
(NASDAQ: CMPS) Delayed: 15.19 +0.19 (1.27%)
Previous Close $15.00    52 Week High $ 
Open $15.10    52 Week Low $ 
Day High $15.43    P/E N/A 
Day Low $14.76    EPS $ 
Volume 3,574,076